Copyright
©The Author(s) 2025.
World J Gastrointest Endosc. Feb 16, 2025; 17(2): 102532
Published online Feb 16, 2025. doi: 10.4253/wjge.v17.i2.102532
Published online Feb 16, 2025. doi: 10.4253/wjge.v17.i2.102532
Table 7 Findings on endoscopy, n (%)
Variable | Endoscopy < 24 hours | Endoscopy > 24 hours |
EGD findings | n = 16 | n = 17 |
Normal | 1 (6.3) | 6 (35.3) |
PUD | 3 (18.8) | 2 (11.8) |
AVM | 1 (6.3) | 2 (11.8) |
Mucosal inflammation | 5 (31.3) | 3 (17.6) |
PHG | 2 (12.5) | 0 |
Solid tumor | 1 (6.3) | 0 |
Dieulafoy | 2 (12.5) | 0 |
Mallory Weiss | 0 | 1 (5.9) |
Cameron lesion | 0 | 2 (11.8) |
Esophagitis | 1 (6.3) | 1 (5.9) |
Colonoscopy findings | n = 6 | n = 5 |
Normal | 2 (33.3) | 2 (40) |
Blood with no source | 1 (16.7) | 2 (40) |
Radiation proctitis | 0 | 1 (20) |
Mucosal ulcer | 1 (16.7) | 0 |
Mucosal inflammation | 2 (33.3) | 0 |
- Citation: Alhumayyd B, Naumann A, Cashen A, Chen CH. Clinical impact of endoscopy in severely thrombocytopenic patients with hematologic malignancy experiencing gastrointestinal bleeding. World J Gastrointest Endosc 2025; 17(2): 102532
- URL: https://www.wjgnet.com/1948-5190/full/v17/i2/102532.htm
- DOI: https://dx.doi.org/10.4253/wjge.v17.i2.102532